of THB 1,117.55 million, increasing THB 113.33 million, or 11.29% from 2017. The increase in revenue is mainly due to the growth in revenue from the Company and subsidiaries in Thailand, which

and its subsidiary for Quarter 2 of 2019 ending on 30 June 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for

685.84 21.11 3.1% Cost of sales -194.96 -208.31 13.35 -6.4% -617.06 -601.34 -15.72 2.6% Gross profit 30.01 25.36 4.65 18.3% 89.89 84.50 5.39 6.4% Other income 1.45 1.26 0.19 15.2% 3.61 5.15 -1.54 -29.9

June 30 2018 Ratio 2018 Ratio 2017 Ratio Increase / (Decrease) Amount Percentage Service revenue 385.75 100% 429.18 100% 355.70 100% 73.48 20.66 Other income 1.43 0.37% 6.53 1.52% 0.88 0.25% 5.64 639.18

and service income (included revenue from finance lease under a Power Purchase Agreement) increase 14.8% YoY from Baht 4,987.6 million to Baht 5,726.9 million, increasing of Baht 739.3 million. The

148.64 154.11 148.23 5.88 3.97 Profit before share loss from investment in joint venture and income tax 19.89 21.82 17.21 22.22 (5.01) (22.55) Share of loss from investment in joint venture (1.00) (0.86

investment in joint venture and income tax 12.38 19.89 9.38 17.21 (7.83) (45.50) Share of loss from investment in joint venture 0.00 (1.00) 0.00 0.00 0.00 N/A Profit before income tax 12.38 18.89 9.38 17.21

- 0.88 -67.89% Other income 36.37 48.96 -12.59 -25.71% 32.89 44.75 - 11.86 -26.50% Total Revenue 1,290.90 1,443.33 -152.43 -10.56% 1,284.81 1,428.01 - 143.20 -10.03% Sharing of gain (loss) from investment

the same period of 2016 ( while utility service income increases) , is attributable to the decrease in central infrastructure maintenance expenditures during this period. ▪ An increasing participating

5.52 14.57 Profit before share loss from investment in joint venture and income tax 2.90 2.83 2.87 2.60 0.27 10.54 Share of loss from investment in joint venture - (1.53) - - - - Profit before income tax